Cellosaurus cell line Sp2/mIL-6 (CVCL

Cellosaurus Sp2/mIL-6 (CVCL_C561)

[Text][XML][JSON]

Cell line name

Sp2/mIL-6

Synonyms

Sp2/MIL6; SP2-IL6

Accession

CVCL_C561

Resource Identification Initiative

To cite this cell line use: Sp2/mIL-6 (RRID:CVCL_C561)

Comments

Group: Hybridoma fusion partner cell line.
Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
Genetic integration: Method=Transduction; Gene=MGI; MGI:96559; Il6.
Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
Cell type: Plasma cell; CL=CL_0000786.

Disease

Mouse multiple myeloma (NCIt: C125417)

Species of origin

Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c.

Hierarchy

Parent: CVCL_2199 (Sp2/0-Ag14)
Children:

CVCL_A8IG (3A1 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IH (3A2 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8II (3A6 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IJ (3A7 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IK (3B1)	CVCL_A8IL (3B3 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IM (3B4 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IN (3B6 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IP (3C2 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IQ (3C4 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IR (3C6 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IS (3D1 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IT (3D2 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IU (3D3 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IV (3D5 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IW (3D7)	CVCL_F0SM (3D9 [Mouse hybridoma against NNK])	CVCL_A8IX (3E1 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8IY (3E4 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8IZ (3E5 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JA (3F1)
CVCL_A8JB (3F2 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JC (3F4 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JD (3F5 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JE (3F6 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JF (3G1 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JG (3G2 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JH (3G6 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JI (3G7)	CVCL_A8JJ (3H2 [Mouse hybridoma against SARS-CoV-2 spike])
CVCL_A8JK (3H4 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_A8JL (3H6)	CVCL_D3TZ (455-2A4)
CVCL_F0SN (4H2 [Mouse hybridoma against NNK])	CVCL_A8JM (5A1 [Mouse hybridoma against SARS-CoV-2 spike])	CVCL_F0WF (7G12 [Mouse hybridoma against NNK])
CVCL_F0WG (8G10 [Mouse hybridoma against NNK])	CVCL_A8JN (9F2)	CVCL_F0AD (anti-ULBP6/2/5)
CVCL_0F32 (IgG-13D3)	CVCL_0F33 (IgG-15A6)	CVCL_F1LF (Sp2/mIL-6 (hTERT))

Sex of cell

Female

Age at sampling

Age unspecified